Voxtalisib
Voxtalisib is a drug which acts as a dual inhibitor of the kinase enzymes phosphatidylinositol 3-kinase and mechanistic target of rapamycin. It is in clinical trials for the treatment of various types of cancer.
Voxtalisib is a drug which acts as a dual inhibitor of the kinase enzymes phosphatidylinositol 3-kinase and mechanistic target of rapamycin. It is in clinical trials for the treatment of various types of cancer.